Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 2 |
GO:0005694 | chromosome | 5 | 7 |
GO:0005730 | nucleolus | 5 | 2 |
GO:0043226 | organelle | 2 | 7 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043228 | non-membrane-bounded organelle | 3 | 7 |
GO:0043229 | intracellular organelle | 3 | 7 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 7 |
GO:0110165 | cellular anatomical entity | 1 | 7 |
Related structures:
AlphaFold database: Q95Z89
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 7 |
GO:0006259 | DNA metabolic process | 4 | 7 |
GO:0006260 | DNA replication | 5 | 2 |
GO:0006265 | DNA topological change | 5 | 7 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 7 |
GO:0006807 | nitrogen compound metabolic process | 2 | 7 |
GO:0006996 | organelle organization | 4 | 7 |
GO:0007059 | chromosome segregation | 2 | 2 |
GO:0008152 | metabolic process | 1 | 7 |
GO:0009987 | cellular process | 1 | 7 |
GO:0016043 | cellular component organization | 3 | 7 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 7 |
GO:0043170 | macromolecule metabolic process | 3 | 7 |
GO:0044237 | cellular metabolic process | 2 | 7 |
GO:0044238 | primary metabolic process | 2 | 7 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 7 |
GO:0046483 | heterocycle metabolic process | 3 | 7 |
GO:0051276 | chromosome organization | 5 | 7 |
GO:0071103 | DNA conformation change | 6 | 7 |
GO:0071704 | organic substance metabolic process | 2 | 7 |
GO:0071840 | cellular component organization or biogenesis | 2 | 7 |
GO:0090304 | nucleic acid metabolic process | 4 | 7 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 7 |
GO:0003677 | DNA binding | 4 | 7 |
GO:0003824 | catalytic activity | 1 | 7 |
GO:0003916 | DNA topoisomerase activity | 3 | 7 |
GO:0003917 | DNA topoisomerase type I (single strand cut, ATP-independent) activity | 4 | 7 |
GO:0005488 | binding | 1 | 7 |
GO:0016853 | isomerase activity | 2 | 7 |
GO:0097159 | organic cyclic compound binding | 2 | 7 |
GO:0140097 | catalytic activity, acting on DNA | 3 | 7 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 7 |
GO:1901363 | heterocyclic compound binding | 2 | 7 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 117 | 121 | PF00656 | 0.602 |
CLV_NRD_NRD_1 | 92 | 94 | PF00675 | 0.625 |
CLV_PCSK_KEX2_1 | 92 | 94 | PF00082 | 0.625 |
CLV_PCSK_SKI1_1 | 158 | 162 | PF00082 | 0.538 |
CLV_PCSK_SKI1_1 | 66 | 70 | PF00082 | 0.653 |
DEG_COP1_1 | 162 | 171 | PF00400 | 0.574 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.608 |
DEG_SPOP_SBC_1 | 94 | 98 | PF00917 | 0.634 |
DOC_CYCLIN_yCln2_LP_2 | 171 | 174 | PF00134 | 0.592 |
DOC_MAPK_gen_1 | 196 | 206 | PF00069 | 0.369 |
DOC_MAPK_gen_1 | 20 | 26 | PF00069 | 0.510 |
DOC_PP2B_LxvP_1 | 171 | 174 | PF13499 | 0.592 |
DOC_PP4_MxPP_1 | 71 | 74 | PF00568 | 0.539 |
DOC_USP7_UBL2_3 | 207 | 211 | PF12436 | 0.304 |
DOC_WW_Pin1_4 | 19 | 24 | PF00397 | 0.563 |
DOC_WW_Pin1_4 | 3 | 8 | PF00397 | 0.705 |
DOC_WW_Pin1_4 | 31 | 36 | PF00397 | 0.524 |
LIG_14-3-3_CanoR_1 | 131 | 140 | PF00244 | 0.590 |
LIG_14-3-3_CanoR_1 | 226 | 232 | PF00244 | 0.369 |
LIG_14-3-3_CanoR_1 | 38 | 42 | PF00244 | 0.550 |
LIG_FHA_1 | 215 | 221 | PF00498 | 0.304 |
LIG_FHA_2 | 160 | 166 | PF00498 | 0.672 |
LIG_FHA_2 | 20 | 26 | PF00498 | 0.595 |
LIG_MYND_1 | 169 | 173 | PF01753 | 0.604 |
LIG_PDZ_Class_2 | 257 | 262 | PF00595 | 0.304 |
LIG_SH2_PTP2 | 222 | 225 | PF00017 | 0.304 |
LIG_SH2_SRC | 222 | 225 | PF00017 | 0.304 |
LIG_SH2_STAT5 | 222 | 225 | PF00017 | 0.304 |
LIG_SH3_3 | 170 | 176 | PF00018 | 0.528 |
LIG_SH3_3 | 5 | 11 | PF00018 | 0.627 |
LIG_SUMO_SIM_par_1 | 22 | 27 | PF11976 | 0.543 |
LIG_TRAF2_1 | 162 | 165 | PF00917 | 0.577 |
LIG_UBA3_1 | 203 | 211 | PF00899 | 0.284 |
LIG_UBA3_1 | 62 | 69 | PF00899 | 0.590 |
LIG_WW_3 | 172 | 176 | PF00397 | 0.516 |
MOD_CDK_SPxxK_3 | 31 | 38 | PF00069 | 0.531 |
MOD_CK1_1 | 104 | 110 | PF00069 | 0.620 |
MOD_CK1_1 | 118 | 124 | PF00069 | 0.690 |
MOD_CK1_1 | 125 | 131 | PF00069 | 0.654 |
MOD_CK1_1 | 132 | 138 | PF00069 | 0.711 |
MOD_CK1_1 | 214 | 220 | PF00069 | 0.304 |
MOD_CK1_1 | 96 | 102 | PF00069 | 0.670 |
MOD_CK2_1 | 131 | 137 | PF00069 | 0.607 |
MOD_CK2_1 | 159 | 165 | PF00069 | 0.516 |
MOD_GlcNHglycan | 101 | 104 | PF01048 | 0.592 |
MOD_GlcNHglycan | 134 | 137 | PF01048 | 0.592 |
MOD_GlcNHglycan | 140 | 143 | PF01048 | 0.548 |
MOD_GlcNHglycan | 243 | 246 | PF01048 | 0.369 |
MOD_GlcNHglycan | 25 | 29 | PF01048 | 0.504 |
MOD_GSK3_1 | 101 | 108 | PF00069 | 0.622 |
MOD_GSK3_1 | 111 | 118 | PF00069 | 0.619 |
MOD_GSK3_1 | 120 | 127 | PF00069 | 0.684 |
MOD_GSK3_1 | 131 | 138 | PF00069 | 0.673 |
MOD_GSK3_1 | 211 | 218 | PF00069 | 0.304 |
MOD_GSK3_1 | 33 | 40 | PF00069 | 0.492 |
MOD_GSK3_1 | 93 | 100 | PF00069 | 0.679 |
MOD_NEK2_1 | 215 | 220 | PF00069 | 0.304 |
MOD_NEK2_1 | 243 | 248 | PF00069 | 0.304 |
MOD_NEK2_2 | 142 | 147 | PF00069 | 0.514 |
MOD_PIKK_1 | 149 | 155 | PF00454 | 0.457 |
MOD_PIKK_1 | 159 | 165 | PF00454 | 0.548 |
MOD_PKA_2 | 130 | 136 | PF00069 | 0.594 |
MOD_PKA_2 | 37 | 43 | PF00069 | 0.639 |
MOD_Plk_1 | 121 | 127 | PF00069 | 0.661 |
MOD_Plk_1 | 142 | 148 | PF00069 | 0.473 |
MOD_Plk_1 | 24 | 30 | PF00069 | 0.524 |
MOD_Plk_2-3 | 116 | 122 | PF00069 | 0.641 |
MOD_Plk_4 | 135 | 141 | PF00069 | 0.629 |
MOD_Plk_4 | 142 | 148 | PF00069 | 0.467 |
MOD_Plk_4 | 167 | 173 | PF00069 | 0.609 |
MOD_ProDKin_1 | 19 | 25 | PF00069 | 0.559 |
MOD_ProDKin_1 | 3 | 9 | PF00069 | 0.704 |
MOD_ProDKin_1 | 31 | 37 | PF00069 | 0.519 |
MOD_SUMO_rev_2 | 208 | 213 | PF00179 | 0.304 |
TRG_DiLeu_BaEn_1 | 167 | 172 | PF01217 | 0.571 |
TRG_ER_diArg_1 | 91 | 93 | PF00400 | 0.628 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IID6 | Leptomonas seymouri | 63% | 100% |
A0A451EJV3 | Leishmania donovani | 96% | 100% |
A4H3S7 | Leishmania braziliensis | 80% | 97% |
A4HS02 | Leishmania infantum | 95% | 100% |
E9AJZ0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |